KR890014088A - 피부의 매끄러움(smoothness)을 향상시키는데 쓰이는 조성물 및 그 매끄러움을 향상시키는 방법 - Google Patents
피부의 매끄러움(smoothness)을 향상시키는데 쓰이는 조성물 및 그 매끄러움을 향상시키는 방법 Download PDFInfo
- Publication number
- KR890014088A KR890014088A KR1019890003524A KR890003524A KR890014088A KR 890014088 A KR890014088 A KR 890014088A KR 1019890003524 A KR1019890003524 A KR 1019890003524A KR 890003524 A KR890003524 A KR 890003524A KR 890014088 A KR890014088 A KR 890014088A
- Authority
- KR
- South Korea
- Prior art keywords
- smoothness
- skin
- acid
- equivalent derivative
- improve
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
- Medicinal Preparation (AREA)
Abstract
내용 없음.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 피부의 조도(粗渡) 파라미터(parameter)(Rz)의 평균길이를 나타낸 형상설명도로서, 피부의 표준길이(주사길이)(L)는 5개의 동일한 세그멘트(segments)로 나누어져 있으며 Rz는 5개의 세그멘트 각각에 있는 최대의 피이크와 골의 높이 평균치이다.
Claims (6)
- 피부의 매끄러움(smoothness)을 향상시키기 위한 약제, 특히 경구용 약제의 제조에서 생리적으로 허용되는 당량유도체 형태의 GLA 또는 DGLA 또는 양자의 사용.
- 피부의 매끄러움을 향상시키기는 조성물, 특히 경구용조성물에 있어서, 생리적으로 허용되는 당량유도체 형태의 GLA 또는 DGLA 또는 양자를 담체(carrier) 또는 희석제(diluent)에 사용하여 투여할 수 있는 형태로 함을 특징으로하는 상기 조성물.
- 제 1항 또는 제 2항에 있어서 GLA 및/또는 DGLA의 양은 산 또는 각 산 또는 몰 당량 유도체를 1일 1mg~100g, 바람직하게는 20mg~2g, 더 바람직하게는 1mg~500mg의 투여량 : 특히 경구투여량에 적합하도록 함을 특징으로 하는 상기 사용 또는 조성물.
- 제 2 항에 있어서, 국소용(topical use)으로 상기 산은 산 또는 각 산 또는 몰당량 유도체 0.001~20wt%, 바람직하게는 0.01~10wt%, 더 바람직하게는 0.05~3wt%의 농도를 가짐을 특징으로 하는 상기 조성물.
- 생리적으로 허용되는 당량 유도체 형태의 GAL 또는 DGLA 또는 양자를 청구범위 제 3항의 1일 사용량으로 하여 투여, 특히 경구함을 특징으로 하는 피부의 매끄러움을 향상시키는 방법.
- 청구범위 제4항의 조성물을 피부에다 청구범위 제3항의 산 또는 몰당량 유도체의 1일 사용량으로 나타낸 양으로 사용함을 특징으로 하는 피부의 매끄러움을 향상시키는 방법.※ 참고사항:최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888806737A GB8806737D0 (en) | 1988-03-22 | 1988-03-22 | Therapeutic composition & method |
GB8806737 | 1988-03-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR890014088A true KR890014088A (ko) | 1989-10-21 |
Family
ID=10633834
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019890003524A KR890014088A (ko) | 1988-03-22 | 1989-03-21 | 피부의 매끄러움(smoothness)을 향상시키는데 쓰이는 조성물 및 그 매끄러움을 향상시키는 방법 |
Country Status (13)
Country | Link |
---|---|
US (1) | US4997657B1 (ko) |
EP (1) | EP0334507B1 (ko) |
JP (1) | JPH02149508A (ko) |
KR (1) | KR890014088A (ko) |
AT (1) | ATE94386T1 (ko) |
AU (1) | AU609952B2 (ko) |
CA (1) | CA1334003C (ko) |
DE (1) | DE68909077T2 (ko) |
GB (1) | GB8806737D0 (ko) |
HK (1) | HK14294A (ko) |
IE (1) | IE63646B1 (ko) |
NZ (1) | NZ228330A (ko) |
ZA (1) | ZA892002B (ko) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0253706A (ja) * | 1988-08-18 | 1990-02-22 | Kurooda Japan Kk | 化粧料組成物 |
GB8920228D0 (en) * | 1989-09-07 | 1989-10-18 | Efamol Holdings | Fatty acid therapy |
CA2119000A1 (en) * | 1993-03-19 | 1994-09-20 | David Frederick Horrobin | Formulation for use in smokers |
US5876438A (en) * | 1993-08-02 | 1999-03-02 | Houston Biotechnology Incorporated | Polymeric device for the delivery of immunotoxins for the prevention of secondary cataract |
AU711482B2 (en) * | 1994-06-28 | 1999-10-14 | Scotia Holdings Plc | Compositions for treatment of diabetic complications |
NO304009B1 (no) * | 1997-02-04 | 1998-10-12 | Gunnar Volden | Hudpreparat |
FR2765482B1 (fr) * | 1997-07-07 | 2000-12-08 | Oreal | Utilisation de l'acide y-linolenique pour prevenir le stress oxydatif |
WO2002083121A1 (fr) * | 2001-04-12 | 2002-10-24 | Katsumori Fukumoto | Compositions servant a ameliorer l'environnement de la peau |
US6688311B2 (en) * | 2002-03-14 | 2004-02-10 | Allergan, Inc. | Method for determining effect of a clostridial toxin upon a muscle |
US7140371B2 (en) * | 2002-03-14 | 2006-11-28 | Allergan, Inc. | Surface topography method for determining effects of a botulinum toxin upon a muscle and for comparing botulinum toxins |
DE10240989A1 (de) * | 2002-09-05 | 2004-03-11 | Uwe Klewinghaus | Zusammensetzung und deren Verwendung als pharmazeutische oder kosmetische Formulierung zur äußerlichen Anwendung |
US20050123500A1 (en) * | 2003-01-31 | 2005-06-09 | The Procter & Gamble Company | Means for improving the appearance of mammalian hair and nails |
MXPA05008216A (es) * | 2003-01-31 | 2005-10-05 | Procter & Gamble | Medios para mejorar la apariencia del tejido queratinoso mamifero. |
ATE425760T1 (de) * | 2003-05-22 | 2009-04-15 | Bioniche Life Sciences Inc | Insektenabwehrmittel |
CA2436650A1 (en) * | 2003-08-06 | 2005-02-06 | Naturia Inc. | Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses |
JP2006306813A (ja) * | 2005-04-28 | 2006-11-09 | Suntory Ltd | 肥満細胞増殖抑制剤 |
CA2599112C (en) | 2005-02-14 | 2013-10-22 | Suntory Limited | Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient |
JP5546087B2 (ja) * | 2005-02-14 | 2014-07-09 | サントリーホールディングス株式会社 | 皮膚疾患経口治療または予防剤 |
JP2006306812A (ja) * | 2005-04-28 | 2006-11-09 | Suntory Ltd | 好酸球浸潤抑制剤 |
DE102007046202A1 (de) * | 2007-09-26 | 2009-04-09 | Schmidt-Philipp, Ingo | Anwendung von Antioxidantien und ausgewählten Fettsäuren zur Linderung oder Verhütung von Schmerzen und anderer unerwünschter Körperreaktionen |
GB0907413D0 (en) | 2009-04-29 | 2009-06-10 | Equateq Ltd | Novel methods |
US8293790B2 (en) | 2011-10-19 | 2012-10-23 | Dignity Sciences Limited | Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof |
JP2012082226A (ja) * | 2012-01-25 | 2012-04-26 | Suntory Holdings Ltd | 皮膚疾患経口治療または予防剤 |
AU2015270418B2 (en) * | 2014-06-04 | 2020-08-06 | Ds Biopharma Limited | Pharmaceutical compositions comprising DGLA and use of same |
JP6214474B2 (ja) * | 2014-06-10 | 2017-10-18 | サントリーホールディングス株式会社 | 皮膚疾患経口治療または予防剤 |
JP6203320B2 (ja) * | 2016-04-12 | 2017-09-27 | サントリーホールディングス株式会社 | 皮膚疾患経口治療または予防剤 |
JP6462790B2 (ja) * | 2017-07-20 | 2019-01-30 | サントリーホールディングス株式会社 | 皮膚疾患経口治療または予防剤 |
WO2024106446A1 (ja) * | 2022-11-15 | 2024-05-23 | 株式会社ニッスイ | アレルギー性鼻炎またはアレルギー性結膜炎の症状の軽減または予防用組成物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4273763A (en) * | 1978-01-23 | 1981-06-16 | Efamol Limited | Pharmaceutical and dietary compositions |
AU556817B2 (en) * | 1982-02-03 | 1986-11-20 | Efamol Limited | Topical application of a lithium salt and dihomo-alpha- linolenic acid |
GB8302708D0 (en) * | 1983-02-01 | 1983-03-02 | Efamol Ltd | Pharmaceutical and dietary composition |
US4568343A (en) * | 1984-10-09 | 1986-02-04 | Alza Corporation | Skin permeation enhancer compositions |
-
1988
- 1988-03-22 GB GB888806737A patent/GB8806737D0/en active Pending
-
1989
- 1989-03-07 DE DE89302265T patent/DE68909077T2/de not_active Revoked
- 1989-03-07 AT AT89302265T patent/ATE94386T1/de active
- 1989-03-07 EP EP89302265A patent/EP0334507B1/en not_active Revoked
- 1989-03-09 CA CA000593435A patent/CA1334003C/en not_active Expired - Fee Related
- 1989-03-09 US US07321204 patent/US4997657B1/en not_active Expired - Fee Related
- 1989-03-09 IE IE76989A patent/IE63646B1/en not_active IP Right Cessation
- 1989-03-10 AU AU31227/89A patent/AU609952B2/en not_active Ceased
- 1989-03-14 NZ NZ228330A patent/NZ228330A/en unknown
- 1989-03-16 ZA ZA892002A patent/ZA892002B/xx unknown
- 1989-03-16 JP JP1062363A patent/JPH02149508A/ja active Pending
- 1989-03-21 KR KR1019890003524A patent/KR890014088A/ko not_active Application Discontinuation
-
1994
- 1994-02-24 HK HK142/94A patent/HK14294A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK14294A (en) | 1994-03-04 |
GB8806737D0 (en) | 1988-04-20 |
EP0334507A3 (en) | 1991-04-17 |
ZA892002B (en) | 1989-11-29 |
IE890769L (en) | 1989-09-22 |
NZ228330A (en) | 1993-10-26 |
JPH02149508A (ja) | 1990-06-08 |
EP0334507B1 (en) | 1993-09-15 |
CA1334003C (en) | 1995-01-17 |
AU609952B2 (en) | 1991-05-09 |
DE68909077T2 (de) | 1994-03-03 |
US4997657A (en) | 1991-03-05 |
EP0334507A2 (en) | 1989-09-27 |
IE63646B1 (en) | 1995-05-31 |
DE68909077D1 (de) | 1993-10-21 |
AU3122789A (en) | 1989-09-28 |
US4997657B1 (en) | 1995-05-02 |
ATE94386T1 (de) | 1993-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR890014088A (ko) | 피부의 매끄러움(smoothness)을 향상시키는데 쓰이는 조성물 및 그 매끄러움을 향상시키는 방법 | |
NO973059L (no) | Hydroksylaminderivater som er anvendbare for å öke den molekylære chaperonproduksjon, og fremstilling derav | |
HUP9903544A2 (hu) | Helyileg alkalmazható anesztetikus hatású gyógyszerkészítmény | |
BR9302738A (pt) | Composicao oral substancialmente nao irritante,com sabor aceitavel | |
KR950702549A (ko) | (3r, 4r)-△^6-테트라하이드로카나비놀-7-오인산(3r, 4r)-△^6-tetrahydrocannabinol-7-oic acids) | |
HUT41759A (en) | Process for producing new pharmaceutical composition containing ipriflavone in form of cyclodextrine inclusion complex | |
DE69005247D1 (de) | Orale Präparate gegen Zahnbeläge. | |
DE3766200D1 (de) | L-dopa enthaltendes arzneimittel. | |
DE3564566D1 (en) | Quinone derivatives, method and use of preparing same, and pharmaceutical composition | |
AU7444087A (en) | Use of usnic acid to prevent dental caries | |
IL102814A0 (en) | Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them | |
GB2210556B (en) | The use of 15-keto-16-halo-prostaglandins in cathartic compositions | |
KR950000663A (ko) | 트리테르펜 유도체 및 이를 함유하는 엔도텔린-수용체 길항물질 | |
DK0631772T3 (da) | Retinoidholdig sammensætning | |
IE40957L (en) | 4- o-ó,d-glucopyranosyl -6-o-ó,d- xylohexopyranosyl -2-¹deoxystreptamine | |
SE8800988D0 (sv) | Pharmaceutical compositons acting on the heart and cardiovascular system and process for preparing same | |
SE9301112D0 (sv) | A new composition | |
AU567455B2 (en) | Composition intended to the hygenic care and health of teeth and of the periodontal tissue of gums | |
ATE151770T1 (de) | Cephalosporinverbindungen und deren herstellung | |
ATE160938T1 (de) | Feste orale pharmazeutische zubereitung mit gemfibrozil als aktiver inhaltsstoff und verfahren zur herstellung | |
KR900009046A (ko) | 치구 억제제 | |
KR880009656A (ko) | 국소 치근막 질환의 치료 또는 예방법 | |
KR930012023A (ko) | 환원된 형태의 비글리코실화 재조합 인체 il2의 안정화된 제약 조성물 및 그의 제조방법 | |
GR3018276T3 (en) | Chewing gum composition, process for the production and use. | |
ATE43594T1 (de) | 3-alkoxy-2-(n-pyrrolidino)-n-pyridyl-n-furyl(od r thienyl)-methyl-propylamine, ihre herstellung und diese enthaltende pharmazeutische mittel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |